Clostridium difficile infection in hospitals: risk factors and responses.
Louie
Thomas J
TJ
Department of Medicine, University of Calgary.
Meddings
Jon
J
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000139:chemically induced / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D003967:Diarrhea / Q000139:chemically induced / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control; D054328:Proton Pump Inhibitors; D011792:Quebec / Q000453:epidemiology; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors